Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target

Biochimie

Volumn 108, Issue , 2015, Pages 1-7

  Zhan, Lei ^a   Huang, Cheng ^a   Meng, Xiao Ming ^a   Song, Yang ^a   Wu, Xiao Qin ^a   Yang, Yang ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hypoxia inducible factor 1alpha; Signaling pathways; Therapeutic target

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUNITINIB; TOPOTECAN; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; HIF1A PROTEIN, HUMAN;

CELL HYPOXIA; DRUG TARGETING; EPIGENETICS; FEEDBACK SYSTEM; HUMAN; LIVER FIBROSIS; NONHUMAN; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; DRUG EFFECTS; LIVER CIRRHOSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PROCEDURES;

ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER CIRRHOSIS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84910045079     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2014.10.013     Document Type: Review

References (86)

1. S.L. Friedman Liver fibrosis - from bench to bedside J. Hepatol. 38 Suppl. 1 2003 S38 S53
2. J.O. Moon, T.P. Welch, F.J. Gonzalez, and B.L. Copple Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice Am. J. Physiol. Gastrointest. Liver Physiol. 296 2009 G582 G592
3. E. Novo, D. Povero, C. Busletta, C. Paternostro, L.V. di Bonzo, S. Cannito, A. Compagnone, A. Bandino, F. Marra, S. Colombatto, E. David, M. Pinzani, and M. Parola The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells J. Pathol. 226 2012 588 597
4. C.W. Pugh, and P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 2003 677 684
5. C. Loenarz, M.L. Coleman, A. Boleininger, B. Schierwater, P.W. Holland, P.J. Ratcliffe, and C.J. Schofield The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens EMBO Rep. 12 2011 63 70
6. G.L. Semenza Hypoxia-inducible factors in physiology and medicine Cell 148 2012 399 408
7. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J. Biol. Chem. 270 1995 1230 1237
8. B.H. Jiang, E. Rue, G.L. Wang, R. Roe, and G.L. Semenza Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 J. Biol. Chem. 271 1996 17771 17778
9. L.E. Huang, Z. Arany, D.M. Livingston, and H.F. Bunn Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit J. Biol. Chem. 271 1996 32253 32259
10. P.J. Kallio, I. Pongratz, K. Gradin, J. McGuire, and L. Poellinger Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor Proc. Natl. Acad. Sci. U. S. A. 94 1997 5667 5672
11. P. Jaakkola, D.R. Mole, Y.M. Tian, M.I. Wilson, J. Gielbert, S.J. Gaskell, A. von Kriegsheim, H.F. Hebestreit, M. Mukherji, C.J. Schofield, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation Science 292 2001 468 472
12. J.W. Jeong, M.K. Bae, M.Y. Ahn, S.H. Kim, T.K. Sohn, M.H. Bae, M.A. Yoo, E.J. Song, K.J. Lee, and K.W. Kim Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation Cell 111 2002 709 720
13. K.S. Hewitson, L.A. McNeill, M.V. Riordan, Y.M. Tian, A.N. Bullock, R.W. Welford, J.M. Elkins, N.J. Oldham, S. Bhattacharya, J.M. Gleadle, P.J. Ratcliffe, C.W. Pugh, and C.J. Schofield Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family J. Biol. Chem. 277 2002 26351 26355
14. L.A. McNeill, K.S. Hewitson, T.D. Claridge, J.F. Seibel, L.E. Horsfall, and C.J. Schofield Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803 Biochem. J. 367 2002 571 575
15. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and M.L. Whitelaw Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch Science 295 2002 858 861
16. P.C. Mahon, K. Hirota, and G.L. Semenza FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity Genes. Dev. 15 2001 2675 2686
17. M.K. Bae, M.Y. Ahn, J.W. Jeong, M.H. Bae, Y.M. Lee, S.K. Bae, J.W. Park, K.R. Kim, and K.W. Kim Jab1 interacts directly with HIF-1alpha and regulates its stability J. Biol. Chem. 277 2002 9 12
18. G.L. Semenza, B.H. Jiang, S.W. Leung, R. Passantino, J.P. Concordet, P. Maire, and A. Giallongo Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 J. Biol. Chem. 271 1996 32529 32537
19. J.I. Bardos, and M. Ashcroft Hypoxia-inducible factor-1 and oncogenic signalling Bioessays 26 2004 262 269
20. B.L. Copple, S. Bai, L.D. Burgoon, and J.O. Moon Hypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis Liver Int. 31 2011 230 244
21. Y. Wang, Y. Huang, F. Guan, Y. Xiao, J. Deng, H. Chen, X. Chen, J. Li, H. Huang, and C. Shi Hypoxia-inducible factor-1alpha and MAPK co-regulate activation of hepatic stellate cells upon hypoxia stimulation PLoS One 8 2013 e74051
22. G.L. Wang, B.H. Jiang, E.A. Rue, and G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc. Natl. Acad. Sci. U. S. A. 92 1995 5510 5514
23. E. Minet, G. Michel, D. Mottet, M. Raes, and C. Michiels Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation Free Radic. Biol. Med. 31 2001 847 855
24. Y.C. Liang, H.G. Wu, H.J. Xue, Q. Liu, L.L. Shi, T. Liu, and G. Wu Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells J. Huazhong Univ. Sci. Technol. Med. Sci. 33 2013 845 851
25. M. Ahmadi, Z. Ahmadihosseini, S.J. Allison, S. Begum, K. Rockley, M. Sadiq, S. Chintamaneni, R. Lokwani, N. Hughes, and R.M. Phillips Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors Br. J. Pharmacol. 171 2014 224 236
26. K.S.S. S, Veeramohan, P. H, T. Mathew, S. S, and M. C Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB Respir. Physiol. Neurobiol. 183 2012 26 34
27. R. Du, K.V. Lu, C. Petritsch, P. Liu, R. Ganss, E. Passegue, H. Song, S. Vandenberg, R.S. Johnson, Z. Werb, and G. Bergers HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell. 13 2008 206 220
28. P. Madanecki, N. Kapoor, Z. Bebok, R. Ochocka, J.F. Collawn, and R. Bartoszewski Regulation of angiogenesis by hypoxia: the role of microRNA Cell. Mol. Biol. Lett. 18 2013 47 57
29. I. Mimura, T. Tanaka, and M. Nangaku Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis Semin. Nephrol. 33 2013 375 382
30. M.P. Nguyen, S. Lee, and Y.M. Lee Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics Arch. Pharm. Res. 36 2013 252 263
31. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
32. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936
33. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 53 2010 976 980
34. E. Novo, S. Cannito, E. Zamara, L. Valfre di Bonzo, A. Caligiuri, C. Cravanzola, A. Compagnone, S. Colombatto, F. Marra, M. Pinzani, and M. Parola Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells Am. J. Pathol. 170 2007 1942 1953
35. C. Corpechot, V. Barbu, D. Wendum, N. Kinnman, C. Rey, R. Poupon, C. Housset, and O. Rosmorduc Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis Hepatology 35 2002 1010 1021
36. K. Sun, I. Wernstedt Asterholm, C.M. Kusminski, A.C. Bueno, Z.V. Wang, J.W. Pollard, R.A. Brekken, and P.E. Scherer Dichotomous effects of VEGF-A on adipose tissue dysfunction Proc. Natl. Acad. Sci. U. S. A. 109 2012 5874 5879
37. P. Fortunato, S. Pillozzi, A. Tamburini, L. Pollazzi, A. Franchi, A. La Torre, and A. Arcangeli Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway BMC Cancer 10 2010 504
38. B.G. Weijts, W.J. Bakker, P.W. Cornelissen, K.H. Liang, F.H. Schaftenaar, B. Westendorp, C.A. de Wolf, M. Paciejewska, C.L. Scheele, L. Kent, G. Leone, S. Schulte-Merker, and A. de Bruin E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1 EMBO J. 31 2012 3871 3884
39. S. Cannito, C. Paternostro, C. Busletta, C. Bocca, S. Colombatto, A. Miglietta, E. Novo, and M. Parola Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases Histol. Histopathol. 29 2014 33 44
40. S. Carbajo-Pescador, R. Ordonez, M. Benet, R. Jover, A. Garcia-Palomo, J.L. Mauriz, and J. Gonzalez-Gallego Inhibition of VEGF expression through blockade of Hif1alpha and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells Br. J. Cancer 109 2013 83 91
41. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, and G.L. Semenza Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol. Cell. Biol. 16 1996 4604 4613
42. D. Chen, W. Tian, Y. Li, W. Tang, and C. Zhang Osteoblast-specific transcription factor Osterix (Osx) and HIF-1alpha cooperatively regulate gene expression of vascular endothelial growth factor (VEGF) Biochem. Biophys. Res. Commun. 424 2012 176 181
43. Y.Q. Wang, J.M. Luk, K. Ikeda, K. Man, A.C. Chu, K. Kaneda, and S.T. Fan Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells Biochem. Biophys. Res. Commun. 317 2004 358 362
44. X.Q. Wu, C. Huang, X. He, Y.Y. Tian, D.X. Zhou, Y. He, X.H. Liu, and J. Li Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer Cell. Signal 25 2013 2462 2468
45. K. Suzuma, K. Naruse, I. Suzuma, N. Takahara, K. Ueki, L.P. Aiello, and G.L. King Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells J. Biol. Chem. 275 2000 40725 40731
46. R.S. Kerbel Tumor angiogenesis N. Engl. J. Med. 358 2008 2039 2049
47. A. Nagai, T. Sado, K. Naruse, T. Noguchi, S. Haruta, S. Yoshida, Y. Tanase, T. Tsunemi, and H. Kobayashi Antiangiogenic-induced hypertension: the molecular basis of signaling network Gynecol. Obstet. Invest 73 2012 89 98
48. M. Jiao, and K.J. Nan Activation of PI3 kinase/Akt/HIF-1alpha pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma Int. J. Oncol. 40 2012 461 468
49. Y.J. Jeong, H.J. Cho, J. Magae, I.K. Lee, K.G. Park, and Y.C. Chang Ascofuranone suppresses EGF-induced HIF-1alpha protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 273 2013 542 550
50. A. Sodhi, S. Montaner, H. Miyazaki, and J.S. Gutkind MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF Biochem. Biophys. Res. Commun. 287 2001 292 300
51. T.N. Brockie, M. Heinzelmann, and J. Gill A framework to examine the role of epigenetics in health disparities among native Americans Nurs. Res. Pract. 2013 2013 410395
52. J. Lee, Y.J. Hwang, K.Y. Kim, N.W. Kowall, and H. Ryu Epigenetic mechanisms of neurodegeneration in Huntington's disease Neurotherapeutics 10 2013 664 676
53. S. Chen, and N. Sang Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors J. Biomed. Biotechnol. 2011 2011 197946
54. J.S. Lee, Y. Kim, J. Bhin, H.J. Shin, H.J. Nam, S.H. Lee, J.B. Yoon, O. Binda, O. Gozani, D. Hwang, and S.H. Baek Hypoxia-induced methylation of a pontin chromatin remodeling factor Proc. Natl. Acad. Sci. U. S. A. 108 2011 13510 13515
55. Y. He, C. Huang, X. Sun, X.R. Long, X.W. Lv, and J. Li MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4 Cell. Signal 24 2012 1923 1930
56. E.C. Lai Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation Nat. Genet. 30 2002 363 364
57. P. Cao, Z. Deng, M. Wan, W. Huang, S.D. Cramer, J. Xu, M. Lei, and G. Sui MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta Mol. Cancer 9 2010 108
58. A. Merlo, S.B. de Quiros, P. Secades, I. Zambrano, M. Balbin, A. Astudillo, B. Scola, M. Aristegui, C. Suarez, and M.D. Chiara Identification of a signaling axis HIF-1alpha/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas J. Clin. Endocrinol. Metab. 97 2012 E2194 E2200
59. Z. Lei, B. Li, Z. Yang, H. Fang, G.M. Zhang, Z.H. Feng, and B. Huang Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration PLoS One 4 2009 e7629
60. A. Taguchi, K. Yanagisawa, M. Tanaka, K. Cao, Y. Matsuyama, H. Goto, and T. Takahashi Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster Cancer Res. 68 2008 5540 5545
61. A.K. Ghosh, T.D. Shanafelt, A. Cimmino, C. Taccioli, S. Volinia, C.G. Liu, G.A. Calin, C.M. Croce, D.A. Chan, A.J. Giaccia, C. Secreto, L.E. Wellik, Y.K. Lee, D. Mukhopadhyay, and N.E. Kay Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells Blood 113 2009 5568 5574
62. V.A. Valera, B.A. Walter, W.M. Linehan, and M.J. Merino Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma J. Cancer 2 2011 515 526
63. A.P. Bird CpG-rich islands and the function of DNA methylation Nature 321 1986 209 213
64. A. Walczak-Drzewiecka, M. Ratajewski, L. Pulaski, and J. Dastych DNA methylation-dependent suppression of HIF1A in an immature hematopoietic cell line HMC-1 Biochem. Biophys. Res. Commun. 391 2010 1028 1032
65. M. Koslowski, U. Luxemburger, O. Tureci, and U. Sahin Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1alpha Oncogene 30 2011 876 882
66. G. Raspaglio, F. Filippetti, S. Prislei, R. Penci, I. De Maria, L. Cicchillitti, S. Mozzetti, G. Scambia, and C. Ferlini Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region Gene 409 2008 100 108
67. K.R. Karch, J.E. Denizio, B.E. Black, and B.A. Garcia Identification and interrogation of combinatorial histone modifications Front. Genet. 4 2013 264
68. A.B. Johnson, N. Denko, and M.C. Barton Hypoxia induces a novel signature of chromatin modifications and global repression of transcription Mutat. Res. 640 2008 174 179
69. E. Hatzimichael, A. Dasoula, R. Shah, N. Syed, A. Papoudou-Bai, H.M. Coley, G. Dranitsaris, K.L. Bourantas, J. Stebbing, and T. Crook The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia Eur. J. Haematol. 84 2010 47 51
70. S.H. Kim, J.W. Jeong, J.A. Park, J.W. Lee, J.H. Seo, B.K. Jung, M.K. Bae, and K.W. Kim Regulation of the HIF-1alpha stability by histone deacetylases Oncol. Rep. 17 2007 647 651
71. J.I. Perez-Perri, J.M. Acevedo, and P. Wappner Epigenetics: new questions on the response to hypoxia Int. J. Mol. Sci. 12 2011 4705 4721
72. J.A. Watson, C.J. Watson, A. McCann, and J. Baugh Epigenetics, the epicenter of the hypoxic response Epigenetics 5 2010 293 296
73. A.M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley Roles of TGF-beta in hepatic fibrosis Front. Biosci. 7 2002 d793 807
74. P. Aukkarasongsup, N. Haruyama, T. Matsumoto, M. Shiga, and K. Moriyama Periostin inhibits hypoxia-induced apoptosis in human periodontal ligament cells via TGF-beta signaling Biochem. Biophys. Res. Commun. 441 2013 126 132
75. T. Watanabe, A. Yasue, and E. Tanaka Inhibition of transforming growth factor beta1/Smad3 signaling decreases hypoxia-inducible factor-1alpha protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells J. Periodontol. 84 2013 1346 1352
76. H. Xie, J.T. Tan, R.L. Wang, X.X. Meng, X. Tang, and S. Gao Expression and significance of HIF-1alpha in pulmonary fibrosis induced by paraquat Exp. Biol. Med. Maywood 238 2013 1062 1068
77. S. Yang, M. Yu, L. Sun, W. Xiao, X. Yang, L. Sun, C. Zhang, Y. Ma, H. Yang, Y. Liu, D. Lu, D.H. Teitelbaum, and H. Yang Interferon-gamma-Induced intestinal epithelial barrier dysfunction by NF-kappaB/HIF-1alpha pathway J. Interferon Cytokine Res. 2013 195 203
78. S.M. Welford, B. Bedogni, K. Gradin, L. Poellinger, M. Broome Powell, and A.J. Giaccia HIF1alpha delays premature senescence through the activation of MIF Genes. Dev. 20 2006 3366 3371
79. T. Yoshida, M. Hashimura, T. Mastumoto, Y. Tazo, H. Inoue, T. Kuwata, and M. Saegusa Transcriptional upregulation of HIF-1alpha by NF-kappaB/p65 and its associations with beta-catenin/p300 complexes in endometrial carcinoma cells Lab. Invest. 93 2013 1184 1193
80. Y.Y. Yang, P.C. Lee, Y.T. Huang, W.P. Lee, Y.J. Kuo, K.C. Lee, Y.C. Hsieh, T.Y. Lee, and H.C. Lin Involvement of the HIF-1alpha and Wnt/beta-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury Clin. Sci. Lond 126 2014 163 174
81. A. Rapisarda, B. Uranchimeg, O. Sordet, Y. Pommier, R.H. Shoemaker, and G. Melillo Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications Cancer Res. 64 2004 1475 1482
82. H. Zhang, D.Z. Qian, Y.S. Tan, K. Lee, P. Gao, Y.R. Ren, S. Rey, H. Hammers, D. Chang, R. Pili, C.V. Dang, J.O. Liu, and G.L. Semenza Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc. Natl. Acad. Sci. U. S. A. 105 2008 19579 19586
83. J.M. Ebos, C.R. Lee, W. Cruz-Munoz, G.A. Bjarnason, J.G. Christensen, and R.S. Kerbel Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis Cancer Cell. 15 2009 232 239
84. S.G. Kang, W.H. Lee, Y.H. Lee, Y.S. Lee, and S.G. Kim Hypoxia-inducible factor-1alpha inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction Carcinogenesis 33 2012 661 669
85. M.S. Kim, H.J. Kwon, Y.M. Lee, J.H. Baek, J.E. Jang, S.W. Lee, E.J. Moon, H.S. Kim, S.K. Lee, H.Y. Chung, C.W. Kim, and K.W. Kim Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes Nat. Med. 7 2001 437 443
86. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat. Rev. Drug Discov. 5 2006 769 784